中国·银河集团www.9873.cσm|官方网站-Made in China

Stock(600222)Hot line:010-61006450

CMC

Committed to the development and innovation of first-class drugs

API R&D Platform

The API and Excipients R&D Platform relies on multiple high-tech platforms and a strong technical development team, which integrates R&D, registration, production and sales functions. It can provide customized synthesis of advanced intermediates, API, impurities, etc., as well as quality research, green production process development, registration and declaration of API, which can meet the requirements for the preparation and production of 0.1 kilograms to several kilograms products in the laboratory, and can undertake research on high-end excipient imitation and substitution projects.


Leadingpharm has built high-end API and excipient development bases in Chongqing , which can carry out the development of raw and excipients materials, imitation and high-end alternative research, high-end preparation research and pilot scale up based on Green chemistry technology.